Quantcast
Last updated on April 18, 2014 at 7:23 EDT

Latest Genetic testing Stories

2013-06-13 16:26:42

Statement from InformedDNA Chief Executive Officer, David P. Nixon ST. PETERSBURG, Fla., June 13, 2013 /PRNewswire-USNewswire/ -- "Today's Supreme Court ruling is an important win for patients everywhere because this decision supports patient choice. This ruling opens the door for additional companies to provide these services. Ultimately, more patients will have timely, affordable access to these important tests, when they are needed. "InformedDNA believes that an equally...

2013-06-13 16:26:23

WASHINGTON, June 13, 2013 /PRNewswire-USNewswire/ -- In a unanimous decision the U.S. Supreme Court has ruled that a person's genes, as they naturally exist in a person's body, are not patentable. The case involved a company, Myriad Genetics, that had patented two DNA sequences related to breast cancer risk, and had exclusive license on the diagnostic tests. (Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO) Of the decision Family Research Council (FRC) Senior Fellow Dr. David...

2013-06-13 16:26:10

In effort to increase access to potentially lifesaving BRCA1 and BRCA2 tests, DNATraits can now offer tests for $995, a fraction of the cost of similar tests prior to the court decision HOUSTON, June 13, 2013 /PRNewswire/ -- Thanks to today's U.S. Supreme Court decision opening the door to greater access to genetic medicine by American patients and their health care providers, testing for genes specifically linked to breast, ovarian and other cancers will now be more widely available...

2013-06-13 12:29:06

Gaithersburg, Md., June 13, 2013 /PRNewswire/ -- GeneDx, one of the world's foremost genetic testing laboratories and a subsidiary of Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today its intention to launch a suite of comprehensive genetic tests for inherited cancers including BRCA1 and BRCA2 genes, given the Supreme Court's ruling in the Association for Molecular Pathology vs. Myriad Genetics case. GeneDx, which was the first commercial laboratory to utilize next generation...

2013-06-12 08:29:16

HELSINKI, June 12, 2013 /PRNewswire/ -- Blueprint Genetics has launched a new genetic testing technology for professional use in hospitals. The gene sequencing technology is based on Stanford University research and can effectively analyse rare hereditary human diseases. The company started its operations in 2012 in Helsinki. The tests of Blueprint Genetics enable efficient diagnosis of difficult hereditary diseases. Today there are almost 4000 recognized diseases with a...

2013-05-30 08:28:24

SAN DIEGO and ST OUEN L'AUMONE, France, May 30, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it, along with its wholly owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), has entered into technology licensing and marketing agreements with Laboratoire Cerba in France for noninvasive prenatal aneuploidy testing. These agreements will expand access to Sequenom CMM's...

2013-05-28 21:28:40

A large scientific study has discovered new genes causing severe seizure disorders that begin in babies and early childhood. The finding will lead to new tests to diagnose these conditions and promises to lead to improved outcomes. Epileptic encephalopathies are severe seizure disorders occurring in infants and children. The seizures are accompanied by slow development and intellectual problems. Pediatric neurologist and researcher Professor Ingrid Scheffer from the University of...

Genetic Testing Pilot Program To Begin In The UK
2013-05-21 05:15:44

Brett Smith for redOrbit.com - Your Universe Online As part of a public-private collaboration, a UK-based charitable foundation has announced a pilot program to genetically test patients for breast and ovarian cancer. “Recent advances in methods for reading the genetic code, known as sequencing, mean that looking for gene mutations is now faster and more affordable than ever before,” according to a statement from the Wellcome Trust. “There is now an opportunity to...

2013-05-17 23:18:03

Fertility Centers of Illinois discusses genetic screening for breast cancer and fertility preservation during a breast cancer diagnosis. Chicago, IL (PRWEB) May 17, 2013 After learning she had an 87 percent risk of breast cancer due to a genetic predisposition through the BRCA1 gene, Angelina Jolie made the decision to undergo a [preventative double mastectomy, lessening her risk to five percent. Angelina´s decision shines the spotlight on genetic predisposition to disease, and what...

2013-05-17 16:23:48

NEW YORK, May 17, 2013 /PRNewswire/ -- Sudler & Hennessey, one of the leading global healthcare communication agencies, announces an agreement between Sudler's eHealth Group and NextGxDx, an online genetic testing marketplace for healthcare providers and hospitals. Emerging trends in healthcare focus on cost, quality, and access to care and information. As personalized medicine continues to expand, and as new genetic tests are introduced daily, integration of these tests into clinical...